Savannah Dunn on September 24, 2010
The European Medicines Agency (EMA), recommended suspension of marketing authorizations for anti-diabetes medicines containing rosiglitazone. These medicines, including Avandia, will stop being available in Europe within the next few months.
The restrictions include:
The FDA states these new restrictions are in response to data that suggest patients treated with Avandia have an elevated risk of cardiovascular events, such as heart attack and stroke.
If you or someone you know is taking Avandia, it is important to talk to your doctor about this new information as you evaluate the available treatment options for Type-2 diabetes, especially if you are known to have underlying heart disease or are at high risk of heart attack.
More than 14,000 Avandia lawsuits have been filed against GlaxoSmithKline. Plaintiffs have alleged that they suffered serious heart conditions as a result of their use of the drug including these Avandia side effects:
Avandia lawsuits seek recovery for physical injury, pain, suffering, lost compensation and medical expenses caused by adverse side effects. Depending on the laws of the particular state where injury occurred and where the Avandia lawsuit is filed, loved ones whose dependents are injured by Avandia side effects may be entitled to file a loss of consortium style lawsuit.
It is in your best interest to consult with an Oklahoma Avandia attorney who fully understands the medical research and legal issues associated with Avandia side effects that have seriously harmed innocent consumers. The Oklahoma Avandia lawyers at McIntyre Law can help protect your rights. Please complete this contact form and one of our staff will contact you immediately, or you can call us toll-free at 1-877-917-5250 for a free evaluation of your Avandia concerns.